LHL

Letoon Holding Ltd. (LHL) is a UK-based biotechnology company specializing in the sustainable extraction of high-value active ingredients and medicinal oils from vegetable waste and botanical matrices. Utilizing a proprietary, scientifically validated ultrasonic reclamation platform, the company produces pharmaceutical-grade compounds, such as lycopene, for use in the pharmaceutical, nutraceutical, and cosmetic industries. LHL operates under rigorous GMP standards and is currently scaling its operations following a significant capital commitment from Nimbus Capital as it prepares for a public listing on the London Stock Exchange. The company's mission is to drive innovation in the circular economy by transforming agricultural byproducts into efficacious ingredients with global industrial demand.